Pulmonx (LUNG) Cash from Financing Activities (2019 - 2025)
Pulmonx (LUNG) reported Cash from Financing Activities of $181000.0 for Q3 2025, down 60.57% year-over-year from $459000.0 in Q3 2024, and up 370.15% on a QoQ basis from -$67000.0 in Q2 2025.
Pulmonx (LUNG) has 7 years of Cash from Financing Activities data on file, last reported at $181000.0 in Q3 2025.
- Quarterly Cash from Financing Activities fell 60.57% year-over-year to $181000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $840000.0 (down 36.27% YoY) and the FY2024 annual result came in at $1.4 million, down 93.63% from the prior year.
- Cash from Financing Activities improved to $181000.0 in Q3 2025 per LUNG's latest filing, from -$67000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $20.7 million in Q1 2023 and bottomed at -$67000.0 in Q2 2025.
- The 5-year median for Cash from Financing Activities is $181000.0 (2025), against an average of $1.6 million.
- The widest annual swing landed in 2022, when Cash from Financing Activities surged 10015.38%; it then plunged 204.55% in 2025.
- Tracing LUNG's Cash from Financing Activities over 5 years: stood at $150000.0 in 2021, then plunged by 55.33% to $67000.0 in 2022, then tumbled by 74.63% to $17000.0 in 2023, then jumped by 264.71% to $62000.0 in 2024, then soared by 191.94% to $181000.0 in 2025.
- Per Business Quant, the three latest LUNG Cash from Financing Activities figures stand at $181000.0 (Q3 2025), -$67000.0 (Q2 2025), and $664000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 181,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Jun 30, 2025 | -67,000.00 |
| Jun 30, 2025 | -67,000.00 |
| Mar 31, 2025 | 664,000.00 |
| Mar 31, 2025 | 664,000.00 |
| Dec 31, 2024 | 62,000.00 |
| Dec 31, 2024 | 62,000.00 |
| Sep 30, 2024 | 459,000.00 |
| Sep 30, 2024 | 459,000.00 |
| Jun 30, 2024 | -22,000.00 |
| Jun 30, 2024 | -22,000.00 |
| Mar 31, 2024 | 864,000.00 |
| Mar 31, 2024 | 864,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 571,000.00 |
| Sep 30, 2023 | 571,000.00 |
| Jun 30, 2023 | 92,000.00 |
| Jun 30, 2023 | 92,000.00 |
| Mar 31, 2023 | 20.72 Mn |
| Mar 31, 2023 | 20.72 Mn |
| Dec 31, 2022 | 67,000.00 |
| Dec 31, 2022 | 67,000.00 |
| Sep 30, 2022 | 906,000.00 |
| Sep 30, 2022 | 906,000.00 |
| Jun 30, 2022 | 131,000.00 |
| Jun 30, 2022 | 131,000.00 |
| Mar 31, 2022 | 1.32 Mn |
| Mar 31, 2022 | 1.32 Mn |
| Dec 31, 2021 | 150,000.00 |
| Dec 31, 2021 | 150,000.00 |
| Sep 30, 2021 | 1.00 Mn |
| Sep 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 3.29 Mn |
| Jun 30, 2021 | 3.29 Mn |
| Mar 31, 2021 | 13,000.00 |
| Mar 31, 2021 | 13,000.00 |
| Dec 31, 2020 | 199.77 Mn |
| Dec 31, 2020 | 199.77 Mn |
| Sep 30, 2020 | 2.36 Mn |
| Sep 30, 2020 | 2.36 Mn |
| Jun 30, 2020 | 31.40 Mn |
| Jun 30, 2020 | 31.40 Mn |
| Mar 31, 2020 | 1.31 Mn |
| Mar 31, 2020 | 1.31 Mn |
| Dec 31, 2019 | -418,000.00 |
| Dec 31, 2019 | -418,000.00 |